These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8932377)

  • 1. Characterization of a protein recognizing minor groove binders-damaged DNA.
    Colella G; Bonfanti M; D'Incalci M; Broggini M
    Nucleic Acids Res; 1996 Nov; 24(21):4227-33. PubMed ID: 8932377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
    Woynarowski JM; Sigmund RD; Beerman TA
    Biochemistry; 1989 May; 28(9):3850-5. PubMed ID: 2473776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
    Coley HM; Mongelli N; D'Incalci M
    Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
    McHugh MM; Sigmund RD; Beerman TA
    Biochem Pharmacol; 1990 Feb; 39(4):707-14. PubMed ID: 1689578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
    Smith PJ; Bell SM; Dee A; Sykes H
    Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin.
    Loskotová H; Brabec V
    Eur J Biochem; 1999 Dec; 266(2):392-402. PubMed ID: 10561579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
    Yamamoto K; Kawanishi S
    Biochem Biophys Res Commun; 1992 Feb; 183(1):292-9. PubMed ID: 1371920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DNA damaging agents on gene expression in two human cancer cell lines.
    Vikhanskaya F; D'Incalci M; Broggini M
    Cell Mol Biol (Noisy-le-grand); 1993 Dec; 39(8):855-62. PubMed ID: 8298434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutagenic properties of DNA minor-groove binding ligands.
    Turner PR; Denny WA
    Mutat Res; 1996 Aug; 355(1-2):141-69. PubMed ID: 8781582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of Hoechst 33258 analogues.
    Gupta R; Wang H; Huang L; Lown JW
    Anticancer Drug Des; 1995 Jan; 10(1):25-41. PubMed ID: 7535056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.
    Bell A; Kittler L; Löber G; Zimmer C
    Invest New Drugs; 1996; 13(4):271-84. PubMed ID: 8824345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
    Yamamoto K; Sugiyama H; Kawanishi S
    Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.
    Bellorini M; Moncollin V; D'Incalci M; Mongelli N; Mantovani R
    Nucleic Acids Res; 1995 May; 23(10):1657-63. PubMed ID: 7784168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
    Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
    Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations induced by some DNA minor groove binding alkylators in AS52 Chinese hamster cells.
    Wu XC; Marcinkowski K; Turner PM; Ferguson LR
    Mutat Res; 2000 Mar; 448(1):35-45. PubMed ID: 10751621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
    Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
    Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258).
    Gravatt GL; Baguley BC; Wilson WR; Denny WA
    J Med Chem; 1994 Dec; 37(25):4338-45. PubMed ID: 7527862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of cytotoxic DNA minor groove binders: alpha-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers.
    Cozzi P
    Farmaco; 2001; 56(1-2):57-65. PubMed ID: 11347968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
    Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
    Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line.
    Erba E; Mascellani E; Pifferi A; D'Incalci M
    Int J Cancer; 1995 Jul; 62(2):170-5. PubMed ID: 7622292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.